leadXpro

leadXpro is a private, Switzerland-based biotechnology company that operates as a specialized service provider and platform company for the drug discovery sector. It leverages advanced structural biology techniques, including CryoEM and time-resolved X-ray crystallography, to elucidate the structure and function of membrane proteins, a historically difficult class of drug targets. The company's business model is built on providing these enabling technologies and services to pharmaceutical partners, aiming to accelerate the early-stage discovery and optimization of novel therapeutics. With a seasoned leadership team of industry veterans and academic pioneers, leadXpro has established a track record with over 100 drug targets to date.

Integrated platform for membrane protein drug discovery, encompassing protein science, biophysics, advanced structural biology (CryoEM, time-resolved X-ray crystallography), and ultra-large virtual screening.

leadXpro competes with broad-based contract research organizations (CROs) offering structural biology services, specialized academic centers, and internal capabilities within large pharmaceutical companies. Its key differentiation is its focused expertise on the technically challenging area of membrane proteins and its potential strategic access to unique large-scale research infrastructure in Switzerland.